FSD Pharma Inks Agreement with Inge, CFO Coyle Signs 6-K
Ticker: QNTM · Form: 6-K · Filed: Feb 26, 2024 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Fsd Pharma Inc. (QNTM) |
| Form Type | 6-K |
| Filed Date | Feb 26, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: agreement, corporate-filing
TL;DR
**FSD Pharma just signed a new agreement with Inge, signaling potential business expansion.**
AI Summary
FSD Pharma Inc. filed a Form 6-K on February 26, 2024, reporting an agreement with Inge. The filing indicates that FSD Pharma, a pharmaceutical preparations company, is a foreign private issuer and files annual reports under Form 20-F. The report was signed by Nathan Coyle, Chief Financial Officer of FSD Pharma Inc., on the same date.
Why It Matters
This filing signals a new business relationship for FSD Pharma, potentially impacting its strategic direction and future financial performance in the pharmaceutical sector.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of an agreement, not indicating any immediate financial distress or significant negative events.
Key Players & Entities
- FSD Pharma Inc. (company) — registrant and filer
- Inge (company) — party to an agreement with FSD Pharma
- Nathan Coyle (person) — Chief Financial Officer of FSD Pharma Inc.
- February 26, 2024 (date) — filing date and signing date
FAQ
What type of agreement did FSD Pharma Inc. sign?
FSD Pharma Inc. signed an agreement with Inge, as indicated in Exhibit 99.1, which is a Press Release.
Who signed the Form 6-K report for FSD Pharma Inc.?
The Form 6-K report was signed by Nathan Coyle, Chief Financial Officer of FSD Pharma Inc.
On what date was this Form 6-K filed?
This Form 6-K was filed on February 26, 2024.
Under which form does FSD Pharma Inc. file its annual reports?
FSD Pharma Inc. indicates by check mark that it files annual reports under cover of Form 20-F.
What is the Commission File Number for FSD Pharma Inc.?
The Commission File Number for FSD Pharma Inc. is 001-39152.
Filing Stats: 146 words · 1 min read · ~1 pages · Grade level 10 · Accepted 2024-02-26 08:04:19
Filing Documents
- fsd_6k.htm (6-K) — 9KB
- fsd_ex991.htm (EX-99.1) — 15KB
- fsd_ex991img2.jpg (GRAPHIC) — 6KB
- 0001654954-24-002170.txt ( ) — 34KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. FSD Pharma Inc. (Registrant) Date: February 26, 2024 By: /s/ Nathan Coyle Nathan Coyle, Chief Financial Officer 2 EXHIBIT INDEX Exhibit Description 99.1 Press Release 3